NovaBridge Biosciences (NBP) Return on Capital Employed (2020 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Return on Capital Employed of 38.94% for Q4 2025, down 1494.0% year-on-year from 2.79% in Q4 2024, and down 153.3% on a QoQ basis from 15.37% in Q3 2025.
NovaBridge Biosciences (NBP) Return on Capital Employed (2020 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Return on Capital Employed for 4 consecutive years, with 38.94% the latest figure, recorded in Q4 2025.
- Quarterly Return on Capital Employed fell 1494.0% year-over-year to 38.94% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 38.94% (down 1494.0% YoY) and the FY2025 annual result came in at 44.95%, down 2674.0% from the prior year.
- Return on Capital Employed declined to 38.94% in Q4 2025 per NBP's latest filing, from 15.37% in the prior quarter.
- Over the last five years, Return on Capital Employed for NBP reached as high as 20274.44% in Q2 2023 and fell as low as 38.94% in Q4 2025.
- A 3-year average of 2874.27% and a median of 23.73% in 2025 frame the typical range for Return on Capital Employed.
- The largest YoY upside for Return on Capital Employed was 1811 bps in 2025 against a maximum downside of 1494 bps in 2025.
- Year by year, Return on Capital Employed stood at 20274.44% in 2023, then plunged by 100 bps to 24.01% in 2024, then plunged by 62 bps to 38.94% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 38.94%, 15.37%, and 19.04% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | -38.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.94% |
| Sep 30, 2025 | -15.37% |
| Jun 30, 2025 | -19.04% |
| Mar 31, 2025 | -23.73% |
| Dec 31, 2024 | -24.01% |
| Sep 30, 2024 | -33.49% |
| Jun 30, 2023 | 20,274.44% |
| Dec 31, 2020 | 12,521.82% |